| Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies (NCT00451022) | National Cancer Institute (NCI) | 2004-09-13 |
| Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data (NCT00341939) | National Cancer Institute (NCI) | 2004-09-07 |
| Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer (NCT00089310) | Alliance for Clinical Trials in Oncology | 2004-09-01 |
| Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer (NCT00735878) | Konstantin Dragnev | 2004-09-01 |
| Topotecan for Irinotecan-Refractory SCLC (NCT00502762) | Gachon University Gil Medical Center | 2004-09-01 |
| Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer (NCT00096226) | Radiation Therapy Oncology Group | 2004-09-01 |
| S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer (NCT00090961) | SWOG Cancer Research Network | 2004-09-01 |
| Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer (NCT00222144) | University of Kansas | 2004-09-01 |
| Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00182806) | Roswell Park Cancer Institute | 2004-09-01 |
| Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery (NCT00281970) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-08-01 |
| Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery (NCT00091039) | National Cancer Institute (NCI) | 2004-08-01 |
| Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel (NCT00215748) | Geriatric Oncology Consortium | 2004-08-01 |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00077311) | Alliance for Clinical Trials in Oncology | 2004-08-01 |
| Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients (NCT00352391) | M.D. Anderson Cancer Center | 2004-08-01 |
| Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy (NCT00093132) | Agennix | 2004-08-01 |
| A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00091663) | Genentech, Inc. | 2004-08-01 |
| Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC) (NCT00084799) | Ludwig Institute for Cancer Research | 2004-07-26 |
| S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00085501) | SWOG Cancer Research Network | 2004-07-01 |
| Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer (NCT00064350) | Eastern Cooperative Oncology Group | 2004-06-28 |
| Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases (NCT00587964) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| Hypofractionated Radiotherapy for Lung Cancer (NCT00214123) | University of Wisconsin, Madison | 2004-06-01 |
| Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene (NCT00588445) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer (NCT00213733) | University Hospital, Strasbourg, France | 2004-06-01 |
| Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00114192) | University of Virginia | 2004-06-01 |
| Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer (NCT00193362) | SCRI Development Innovations, LLC | 2004-06-01 |
| A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer (NCT00585533) | University of Utah | 2004-06-01 |
| Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer (NCT00062010) | Eastern Cooperative Oncology Group | 2004-05-26 |
| Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer (NCT00899405) | University of California, Davis | 2004-05-19 |
| Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants (NCT00444223) | Jonsson Comprehensive Cancer Center | 2004-05-04 |
| Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors (NCT00078845) | M.D. Anderson Cancer Center | 2004-05-01 |
| Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer (NCT00274898) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2004-05-01 |
| Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT00096486) | Memorial Sloan Kettering Cancer Center | 2004-05-01 |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer (NCT00087438) | Radiation Therapy Oncology Group | 2004-05-01 |
| Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer (NCT00132054) | Japan Multinational Trial Organization | 2004-05-01 |
| Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC (NCT00280735) | UNC Lineberger Comprehensive Cancer Center | 2004-05-01 |
| Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00091156) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-05-01 |
| Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors (NCT00610844) | University Hospital Tuebingen | 2004-04-01 |
| Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer (NCT00193427) | SCRI Development Innovations, LLC | 2004-04-01 |
| Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer (NCT00242983) | National Hospital Organization Kinki-chuo Chest Medical Center | 2004-04-01 |
| Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer (NCT00087048) | Case Comprehensive Cancer Center | 2004-04-01 |
| A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer (NCT00238628) | Stanford University | 2004-04-01 |
| 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer (NCT00077415) | Cancer Therapeutics Research Group | 2004-04-01 |
| Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials (NCT00500513) | M.D. Anderson Cancer Center | 2004-04-01 |
| Lung Cancer Case Registry and Tissue Resource (NCT00250848) | University of New Mexico | 2004-03-01 |
| Internet-based System for Cancer Patients to Self-report Toxicity (NCT00578006) | Memorial Sloan Kettering Cancer Center | 2004-03-01 |
| Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer (NCT00081302) | Radiation Therapy Oncology Group | 2004-03-01 |
| The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules (NCT00598065) | Memorial Sloan Kettering Cancer Center | 2004-03-01 |
| S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer (NCT00074295) | SWOG Cancer Research Network | 2004-03-01 |
| Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors (NCT00096707) | Threshold Pharmaceuticals | 2004-02-01 |
| Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC) (NCT00664105) | Vanderbilt-Ingram Cancer Center | 2004-02-01 |
| Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions (NCT00077324) | Alliance for Clinical Trials in Oncology | 2004-02-01 |
| Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. (NCT00226577) | H. Lee Moffitt Cancer Center and Research Institute | 2004-02-01 |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer (NCT00287963) | Medical University of South Carolina | 2004-02-01 |
| Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer (NCT00526461) | Roswell Park Cancer Institute | 2004-02-01 |
| Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00103389) | Cellxpert Biotechnology Corp. | 2004-02-01 |
| Eligibility Screening for the NIH Intramural Research Program Clinical Protocols (NCT00026754) | National Cancer Institute (NCI) | 2004-01-14 |
| Minimum Dose CT Post Lung Biopsy (NCT00188162) | University Health Network, Toronto | 2004-01-01 |
| Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer (NCT00449020) | University of Miami | 2004-01-01 |
| Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer (NCT00305617) | The Cleveland Clinic | 2004-01-01 |
| Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer (NCT00898313) | Vanderbilt-Ingram Cancer Center | 2003-12-01 |
| Zinc Supplements in Lowering Cadmium Levels in Smokers (NCT00376987) | Wake Forest University Health Sciences | 2003-12-01 |
| Effectiveness of KOS-862 in the Treatment of Lung Cancer (NCT00080509) | Bristol-Myers Squibb | 2003-12-01 |
| Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00070486) | Alliance for Clinical Trials in Oncology | 2003-12-01 |
| Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy (NCT00081107) | Memorial Sloan Kettering Cancer Center | 2003-12-01 |
| Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00118131) | University of Medicine and Dentistry of New Jersey | 2003-12-01 |
| Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00469898) | Vanderbilt-Ingram Cancer Center | 2003-12-01 |
| Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer (NCT00422500) | M.D. Anderson Cancer Center | 2003-11-01 |
| Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00072527) | Alliance for Clinical Trials in Oncology | 2003-11-01 |
| Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00217698) | Swiss Cancer Institute | 2003-11-01 |
| Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00310154) | Wake Forest University Health Sciences | 2003-11-01 |
| Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer (NCT00483639) | Vanderbilt-Ingram Cancer Center | 2003-11-01 |
| Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00075374) | Case Comprehensive Cancer Center | 2003-10-01 |
| Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00074204) | Case Comprehensive Cancer Center | 2003-10-01 |
| Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy (NCT00068289) | SWOG Cancer Research Network | 2003-09-01 |
| Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer (NCT00098085) | Agenus Inc. | 2003-09-01 |
| CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) (NCT00346801) | M.D. Anderson Cancer Center | 2003-09-01 |
| Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00075517) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2003-09-01 |
| Early Lung Cancer Detection Using Computed Tomography (NCT00188734) | University Health Network, Toronto | 2003-09-01 |
| Italian Lung Cancer Screening Trial (ITALUNG) (NCT02777996) | Cancer Prevention and Research Institute, Italy | 2003-09-01 |
| ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer (NCT00077246) | Memorial Sloan Kettering Cancer Center | 2003-09-01 |
| Genetic Epidemiology of Lung Cancer (NCT00341835) | National Human Genome Research Institute (NHGRI) | 2003-08-26 |
| Health Communication in Families (NCT00597961) | Memorial Sloan Kettering Cancer Center | 2003-08-12 |
| Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung (NCT00277082) | University of New Mexico | 2003-08-01 |
| Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer (NCT00193375) | SCRI Development Innovations, LLC | 2003-08-01 |
| Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00072072) | Jonsson Comprehensive Cancer Center | 2003-08-01 |
| Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00094822) | Amgen | 2003-07-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors (NCT00066651) | National Cancer Institute (NCI) | 2003-07-01 |
| Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00072059) | Jonsson Comprehensive Cancer Center | 2003-07-01 |
| S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors (NCT00062439) | SWOG Cancer Research Network | 2003-07-01 |
| Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer (NCT00063258) | M.D. Anderson Cancer Center | 2003-06-01 |
| Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia (NCT00056004) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) (NCT00101920) | Amgen | 2003-06-01 |
| Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00083161) | Gundersen Lutheran Health System | 2003-06-01 |
| Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy (NCT00077064) | Radiation Therapy Oncology Group | 2003-06-01 |
| Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00073866) | Northwestern University | 2003-06-01 |
| Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer (NCT00068653) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00066222) | Radiation Therapy Oncology Group | 2003-06-01 |
| Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer (NCT00104793) | Japan Multinational Trial Organization | 2003-06-01 |
| Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities (NCT00130143) | The Dale & Frances Hughes Cancer Center | 2003-06-01 |
| Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer (NCT00465907) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2003-05-01 |